United Kingdom Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliveryReport Details:Publish...
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth....
5.2 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 465.3 Insulin Delivery Market, United Kingdom, Segment...
6.13 ARKRAY, Inc. 856.13.1 Company Overview 856.14 B. Braun Melsungen AG 866.14.1 Company Overview 867 Diabetes Care Devic...
Table 8: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 26Table 9: Glucose ...
Table 32: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-201871Table 33: Insulin Delivery, U...
2011-2018 39Figure 20: Glucose Monitoring, United Kingdom, Company Share (%), 2011 43Figure 21: Insulin Delivery, Market S...
Upcoming SlideShare
Loading in …5
×

United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

160 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
160
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

  1. 1. United Kingdom Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 101Price: Single User License – US$2500United Kingdom Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and InsulinDeliverySummaryGlobalData’s new report, “United Kingdom Diabetes Care Devices Market Outlook to 2018-Glucose Monitoring and Insulin Delivery” provides key market data on the United KingdomDiabetes Care Devices market. The report provides value (USD million), volume (units) andaverage price (USD) data for each segment and sub-segment within two market categories –Glucose Monitoring and Insulin Delivery. The report also provides company shares anddistribution shares data for each of the aforementioned market categories. The report issupplemented with global corporate-level profiles of the key market participants with informationon company financials and pipeline products, wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the United Kingdom DiabetesCare Devicesmarket.- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Sanofi, Eli Lilly andCompany, LifeScan, Inc., Becton, Dickinson and Company and others.
  2. 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the United Kingdom DiabetesCare Devices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197482-united-kingdom-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 72 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices In United Kingdom 103.1 Diabetes Care Devices, Market Segmentation 103.2 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 113.3 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2011 123.4 Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 133.5 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 204 Glucose Monitoring In United Kingdom 224.1 Glucose Monitoring, Market Segmentation 224.2 Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2011 234.3 Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 244.4 Glucose Monitoring Overall Revenue, (2004-2018) 254.4.1 Blood Glucose Meters, Revenue (2004-2018) 294.5 Glucose Monitoring Overall Volume (2004-2018) 334.5.1 Blood Glucose Meters, Volume (2004-2018) 374.6 Glucose Monitoring Average Price (2004-2018) 414.7 Glucose Monitoring Distribution Share (2010-2011) 424.8 Glucose Monitoring, United Kingdom, Company Share (2010-2011) 435 Insulin Delivery In United Kingdom 455.1 Insulin Delivery, Market Segmentation 45
  3. 3. 5.2 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 465.3 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 475.4 Insulin Delivery Overall Revenue, (2004-2018) 485.4.1 Insulin Pens, Revenue (2004-2018) 525.4.2 Insulin Pumps, Revenue (2004-2018) 565.5 Insulin Delivery Overall Volume (2004-2018) 605.5.1 Insulin Pens, Volume (2004-2018) 645.5.2 Insulin Pumps, Volume (2004-2018) 685.6 Insulin Delivery Average Price (2004-2018) 725.7 Insulin Delivery Distribution Share (2010-2011) 745.8 Insulin Delivery, United Kingdom, Company Share (2010-2011) 756 Overview of Key Companies in United Kingdom Diabetes Care Devices Market 776.1 F. Hoffmann-La Roche Ltd. 776.1.1 Company Overview 776.1.2 Share in the United Kingdom Diabetes Care Devices Market 776.2 Novo Nordisk A/S 786.2.1 Company Overview 786.2.2 Share in the United Kingdom Diabetes Care Devices Market 786.3 Sanofi 796.3.1 Company Overview 796.3.2 Share in the United Kingdom Diabetes Care Devices Market 796.4 Eli Lilly and Company 806.4.1 Company Overview 806.4.2 Share in the United Kingdom Diabetes Care Devices Market 806.5 LifeScan, Inc. 816.5.1 Company Overview 816.5.2 Share in the United Kingdom Diabetes Care Devices Market 816.6 Becton, Dickinson and Company 826.6.1 Company Overview 826.6.2 Share in the United Kingdom Diabetes Care Devices Market 826.7 Bayer HealthCare AG 836.7.1 Company Overview 836.8 Abbott Laboratories 836.8.1 Company Overview 836.9 Medtronic, Inc. 846.9.1 Company Overview 846.10 Animas Corporation 846.10.1 Company Overview 846.11 Ypsomed Holding AG 856.11.1 Company Overview 856.12 Home Diagnostics (UK) Limited 856.12.1 Company Overview 85
  4. 4. 6.13 ARKRAY, Inc. 856.13.1 Company Overview 856.14 B. Braun Melsungen AG 866.14.1 Company Overview 867 Diabetes Care Devices Market Pipeline Products 878 Financial Deals Landscape 918.1 Partnerships 918.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 918.1.2 Mendor Enters Into Distribution Agreement With Merck Serono 929 Recent Developments 939.1 Research And Development 939.1.1 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective DrugResearch 939.2 Product News 949.2.1 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To ImprovePatient Care 9410 Appendix 9510.1 Definitions of Markets Covered in the Report 9610.1.1 Diabetes Care Devices 9610.2 Research Methodology 9810.3 Secondary Research 9810.4 Primary Research 9910.5 Models 9910.6 Forecasts 10010.7 Expert Panels 10010.8 GlobalData Consulting 10010.9 Currency Conversion 10010.10 Contact Us 10110.11 Disclaimer 1011.1 List of TablesTable 1: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13Table 3: Diabetes Care Devices, United Kingdom, Cross-Segment Analysis, 2004-2018 15Table 4: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic,2004-2011 17Table 5: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant,Forecast, 2011-2018 19Table 6: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($m), USDConstant, 2010-2011 21Table 7: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24
  5. 5. Table 8: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 26Table 9: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 28Table 10: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 30Table 11: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 32Table 12: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2004-201134Table 13: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2011-201836Table 14: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic,2004-2011 38Table 15: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast,2011-2018 40Table 16: Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2004-2011 41Table 17: Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2011-2018 41Table 18: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USDConstant, 2010-2011 42Table 19: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USDConstant, 2010-2011 44Table 20: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47Table 21: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 49Table 22: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 51Table 23: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 53Table 24: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 55Table 25: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 57Table 26: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 59Table 27: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 61Table 28: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 63Table 29: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 65Table 30: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-201867Table 31: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-201169
  6. 6. Table 32: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-201871Table 33: Insulin Delivery, United Kingdom, Average Price ($), Historic, 2004-2011 72Table 34: Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2011-2018 73Table 35: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Constant,2010-2011 74Table 36: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Constant,2010-2011 76Table 37: Diabetes Care Devices Market Pipeline Products 87Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 91Table 39: Mendor Enters Into Distribution Agreement With Merck Serono 921.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 11Figure 3: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2011 12Figure 4: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2011 13Figure 5: Diabetes Care Devices, United Kingdom, Cross-Segment Analysis, 2004-2018 14Figure 6: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic,2004-2011 16Figure 7: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant,Forecast, 2011-2018 18Figure 8: Diabetes Care Devices, United Kingdom, Company Share (%), 2011 20Figure 9: Glucose Monitoring, Market Segmentation 22Figure 10: Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2011 23Figure 11: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2011 24Figure 12: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment,Historic, 2004-2011 25Figure 13: Glucose Monitoring, United Kingdom, Revenue ($m) USD Constant, by Segment,Forecast, 2011-2018 27Figure 14: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 29Figure 15: Blood Glucose Meters, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 31Figure 16: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2004-201133Figure 17: Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 35Figure 18: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic,2004-2011 37Figure 19: Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast,
  7. 7. 2011-2018 39Figure 20: Glucose Monitoring, United Kingdom, Company Share (%), 2011 43Figure 21: Insulin Delivery, Market Segmentation 45Figure 22: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2011 46Figure 23: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2011 47Figure 24: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Historic,2004-2011 48Figure 25: Insulin Delivery, United Kingdom, Revenue ($m) USD Constant, by Segment, Forecast,2011-2018 50Figure 26: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 52Figure 27: Insulin Pens, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 54Figure 28: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 56Figure 29: Insulin Pumps, United Kingdom, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 58Figure 30: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2004-2011 60Figure 31: Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2011-2018 62Figure 32: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-2011 64Figure 33: Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-201866Figure 34: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2004-201168Figure 35: Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2011-201870Figure 36: Insulin Delivery, United Kingdom, Company Share (%), 2011 75Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),United Kingdom Diabetes CareDevices Market, 2011 77Figure 38: Novo Nordisk A/S, Company Share (%),United Kingdom Diabetes Care DevicesMarket, 2011 78Figure 39: Sanofi, Company Share (%),United Kingdom Diabetes Care Devices Market, 2011 79Figure 40: Eli Lilly and Company, Company Share (%),United Kingdom Diabetes Care DevicesMarket, 2011 80Figure 41: LifeScan, Inc., Company Share (%),United Kingdom Diabetes Care Devices Market,2011 81Figure 42: Becton, Dickinson and Company, Company Share (%),United Kingdom Diabetes CareDevices Market, 2011 82Contact: sales@reportsandreports.com for more information.

×